Platform technology IP adds to vaccine challenge
· mari serebrov
AI Briefing
- • Platform technology can speed vaccine development in unexpected outbreaks like Ebola and hantavirus.
- • Existing platforms are protected by intellectual property, adding economic hurdles for smaller vaccine developers.
- • Smaller vaccine developers face challenges due to IP protecting platform technology, says patent attorney.
Context
Platform delivery technologies can aid in vaccine development by speeding up the process for unexpected viral outbreaks, such as the recent Bundibugyo Ebola and Andes hantavirus outbreaks. Existing platforms can target these new viruses.
The intellectual property protecting these platforms poses economic hurdles for smaller vaccine developers, according to Douglas Bucklin, a life sciences patent attorney with Volpe Koenig.
Advertisement